Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07087821 · ClinicalTrials.gov registry record · NA
NYU Epilepsy Self-Management Study
A NA study, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT07087821 is a NA study that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 108 participants.
The verdict
NCT07087821, a NA study, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
The investigators will conduct two-arm randomized controlled trials (RCTs) comparing effects of UPLIFT vs. enhanced usual care and PACES vs. enhanced usual care, respectively, on quality of life, depressive symptoms and seizures over 12 months in NYU patients with epilepsy.
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL UPLIFT
- BEHAVIORAL PACES
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2025-09-16 |
| Est. Completion | 2027-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07087821
The ClinicalTrials.gov registry entry for NCT07087821 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Enhanced Usual Care is the first listed.
NCT07087821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07087821 about?
NCT07087821 is a clinical study titled "NYU Epilepsy Self-Management Study". The investigators will conduct two-arm randomized controlled trials (RCTs) comparing effects of UPLIFT vs. enhanced usual care and PACES vs. enhanced usual care, respectively, on quality of life, depressive symptoms and seizures over 12 months in NYU patients with epilepsy.
What is the current status of trial NCT07087821?
This trial is currently recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2025-09-16. Estimated completion is 2027-09-29.
What interventions are being tested in trial NCT07087821?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), UPLIFT (BEHAVIORAL), PACES (BEHAVIORAL).
Who is sponsoring clinical trial NCT07087821?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.